Brain Cancer
Cerebral Glioblastoma
Male, 48 years
Patient Internal 500182761
ICD-10 code
C71.8 Malignant Neoplasm of Overlapping Sites of Brain
Diagnosis (Incl. Metastases/Stage) and Year
May 2021
Cerebral Glioblastoma G4, IDH (-), TERT (+), Monosomy of Chromosome 10, EGFR1 amplification, MGMT (+), Ki67 – 20%. The patient is Post-Craniotomy with disease recurrence after 1 month.
Previous Treatment
Surgery, Radiation Therapy, Chemotherapy (Temozolomide and Lomustin)
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of 14 months from diagnosis.
Treatment Provided
Autologous DCV (8 doses) and CIK (4 doses) over a period of 10 months.
Patient Survival/Condition and Year
Date of Review: 15/10/2023
The patient has lived for 23 months after the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy and Radiation Therapy, has extended the patient’s survival by about 9 months from median survival.
